348 related articles for article (PubMed ID: 29200846)
1. Improved resection and prolonged overall survival with PD-1-IRDye800CW fluorescence probe-guided surgery and PD-1 adjuvant immunotherapy in 4T1 mouse model.
Du Y; Sun T; Liang X; Li Y; Jin Z; Xue H; Wan Y; Tian J
Int J Nanomedicine; 2017; 12():8337-8351. PubMed ID: 29200846
[TBL] [Abstract][Full Text] [Related]
2. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
[TBL] [Abstract][Full Text] [Related]
3. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
[TBL] [Abstract][Full Text] [Related]
4. Development of a Novel Histone Deacetylase-Targeted Near-Infrared Probe for Hepatocellular Carcinoma Imaging and Fluorescence Image-Guided Surgery.
Tang C; Du Y; Liang Q; Cheng Z; Tian J
Mol Imaging Biol; 2020 Jun; 22(3):476-485. PubMed ID: 31228075
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma.
Prince AC; McGee AS; Siegel H; Rosenthal EL; Behnke NK; Warram JM
J Surg Oncol; 2018 May; 117(6):1179-1187. PubMed ID: 29284070
[TBL] [Abstract][Full Text] [Related]
6. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
[TBL] [Abstract][Full Text] [Related]
7. Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging.
Alam MK; El-Sayed A; Barreto K; Bernhard W; Fonge H; Geyer CR
Mol Imaging Biol; 2019 Feb; 21(1):54-66. PubMed ID: 29948640
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection.
Li L; Du Y; Chen X; Tian J
Mol Imaging Biol; 2018 Dec; 20(6):930-939. PubMed ID: 29651576
[TBL] [Abstract][Full Text] [Related]
9. Near-infrared fluorescence-labeled anti-PD-L1-mAb for tumor imaging in human colorectal cancer xenografted mice.
Zhang M; Jiang H; Zhang R; Jiang H; Xu H; Pan W; Gao X; Sun Z
J Cell Biochem; 2019 Jun; 120(6):10239-10247. PubMed ID: 30609118
[TBL] [Abstract][Full Text] [Related]
10. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
[No Abstract] [Full Text] [Related]
11. High-precision tumor resection down to few-cell level guided by NIR-IIb molecular fluorescence imaging.
Wang F; Qu L; Ren F; Baghdasaryan A; Jiang Y; Hsu R; Liang P; Li J; Zhu G; Ma Z; Dai H
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2123111119. PubMed ID: 35380898
[TBL] [Abstract][Full Text] [Related]
12. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
[TBL] [Abstract][Full Text] [Related]
13. A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma.
Baart VM; van der Horst G; Deken MM; Bhairosingh SS; Schomann T; Sier VQ; van der Mark MH; Iamele L; de Jonge H; Resnati M; Mazar AP; Pelger RCM; van der Pluijm G; Kuppen PJK; Vahrmeijer AL; Sier CFM
Eur J Cancer; 2021 Mar; 146():11-20. PubMed ID: 33561783
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a novel ovarian cancer-specific fluorescent antibody probe for targeted near-infrared fluorescence imaging.
Chen J; Zhang C; Guo Y; Chang X; Ma R; Ye X; Cheng H; Li Y; Cui H
World J Surg Oncol; 2020 Apr; 18(1):66. PubMed ID: 32252772
[TBL] [Abstract][Full Text] [Related]
15. Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
Muselaers CH; Stillebroer AB; Rijpkema M; Franssen GM; Oosterwijk E; Mulders PF; Oyen WJ; Boerman OC
J Nucl Med; 2014 Jun; 55(6):1035-40. PubMed ID: 24752673
[TBL] [Abstract][Full Text] [Related]
16. Multimodal image-guided surgery of HER2-positive breast cancer using [
Deken MM; Bos DL; Tummers WSFJ; March TL; van de Velde CJH; Rijpkema M; Vahrmeijer AL
EJNMMI Res; 2019 Nov; 9(1):98. PubMed ID: 31754913
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Study of a Fully Human Anti-PD-L1 Antibody as a Theranostic Agent for Cancer Immunotherapy.
Xu M; Han Y; Liu G; Xu Y; Duan D; Liu H; Du F; Luo P; Liu Z
Mol Pharm; 2018 Oct; 15(10):4426-4433. PubMed ID: 30133286
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared dye-labeled antibody COC183B2 enables detection of tiny metastatic ovarian cancer and optimizes fluorescence-guided surgery.
Chen J; Guo Y; Li H; Zhang C; Chang X; Ma R; Cheng H; Ye X; Cui H; Li Y
J Surg Oncol; 2020 Nov; 122(6):1207-1217. PubMed ID: 32705686
[TBL] [Abstract][Full Text] [Related]
19. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models.
Zhang M; Kobayashi N; Zettlitz KA; Kono EA; Yamashiro JM; Tsai WK; Jiang ZK; Tran CP; Wang C; Guan J; Wu AM; Reiter RE
Clin Cancer Res; 2019 Jan; 25(1):188-200. PubMed ID: 30301826
[TBL] [Abstract][Full Text] [Related]
20. Nuclear and Fluorescent Labeled PD-1-Liposome-DOX-
Du Y; Liang X; Li Y; Sun T; Jin Z; Xue H; Tian J
Mol Pharm; 2017 Nov; 14(11):3978-3986. PubMed ID: 29016143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
